Literature DB >> 3522820

Intraperitoneal chemotherapy: a review.

D E Brenner.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3522820     DOI： 10.1200/JCO.1986.4.7.1135

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.

Authors:  G Los; P H Mutsaers; W J Lenglet; G S Baldew; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases.

Authors:  S Schneebaum; M W Arnold; A Staubus; D C Young; D Dumond; E W Martin
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

3.  A new intraperitoneal tumor model in the rat.

Authors:  J D Nagel; G Los; A C Begg; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.

Authors:  L T Vlasveld; B G Taal; B B Kroon; M P Gallee; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.

Authors:  G Los; L Tuyt; M van Vugt; J Schornagel; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis.

Authors:  Michael A Ströhlein; Robert Siegel; Michael Jäger; Horst Lindhofer; Karl-Walter Jauch; Markus M Heiss
Journal:  J Exp Clin Cancer Res       Date:  2009-02-14

7.  The optimal starting time of postoperative intraperitoneal mitomycin-C therapy with preserved intestinal wound healing.

Authors:  Ali Uzunkoy; Cengiz Bolukbas; Mehmet Horoz; Fusun F Bolukbas; Abdurrahim Kocyigit
Journal:  BMC Cancer       Date:  2005-03-31       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.